Advanced Oncotherapy (AVO) LIGHT machine trials confirm system on track to treat tumours by end Q3 2018

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it remains on schedule with the development of the first LIGHT system, with successful integration of three key elements of the device. The first Side Coupled Drift Tube Linac (“SCDTL”) accelerating module has been integrated with the Radiofrequency Quadrupole […]

Advanced Oncotherapy (AVO) – Director dealing

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that yesterday Dr Enrico Vanni, Non-Executive Director of the Company, purchased 100,000 ordinary shares of 25 pence in the Company at a price of 17.75 pence per Ordinary Share. Following this transaction, Dr Vanni now holds 1,223,946 Ordinary Shares, representing 1.51% of the […]

Advanced Oncotherapy (AVO) – Technological milestones update – CCL units

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the completion of a further technological milestone in the manufacture of its first LIGHT system. Delivery of CCLs The Company confirms that the final Coupled Cavity Linac (CCL) module, to be used to generate a beam capable of treating superficial […]

AVO – More LIGHT at the end of the tunnel – Wall Street Wires

by Spekulator at Wall Street Wires Quick reminder. I am an active investor into smaller companies where I see (a) genuine value (b) good management (c) an unusual or groundbreaking product. Mostly a,b and c have to be present and correct, but I will make exceptions. I am invested into companies listed on Nasdaq, London […]

Advanced Oncotherapy (AVO) – Result of AGM

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed. For further information, please contact: Advanced Oncotherapy Plc www.avoplc.com Dr. Michael Sinclair, Executive Chairman Tel: +44 20 3617 8728 Nicolas Serandour, CEO Stockdale Securities (Nomad & Joint Broker) Antonio […]

Advanced Oncotherapy (AVO) – Financing facility provided by significant shareholders

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a consortium formed by AB Segulah and other investors has made available a £3.9m loan to the Company.  The loan will have a two year maturity and a 12% per annum rolled up interest rate.  The Segulah group includes AB Segulah, a […]

Advanced Oncotherapy (AVO) – Video and update on progress at Harley Street

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the release of a short video providing an update on the facility at Harley Street and progress made on site. The video features Deconstruct (UK) Limited, principal contractor to the project, and highlights its role in the demolition, excavation and rebuild at […]

Bilby – Largest Gas Contractor in South East, Doubles Revenue

Bilby plc BILB With revenue doubling in the year to 31st March and gross profit rising from £6m. to £11.02m.,  Bilby has established itself as the largest gas contractor in London and the South East. However after various non underlying items, profit before tax fell from a restated £0.72m in 2016 to this years £0.06m.  […]